2020-01-30T13:00:00

  days

  hours  minutes  seconds

until

Exploring Real World Evidence

in Bratislava, Slovakia

Based on data from the World Health Organization, the situation with cancer mortality in Slovakia has improved significantly over the past years particularly in bronchus, lung and trachea cancers. In order to pursue further improvements in cancer mortality, it is of utmost importance to address the infrastructure issues by leveraging modern approaches in a variety of healthcare domains as well as by attracting clinical and preclinical research in precision medicine to Slovakia. Our company WHISE-Embleema is a key player in the area of personalized medicine driven digital healthcare and by studying Slovakia’s health profile we recognize its potential to attract significant interest in this domain.

We are pleased to invite you to the healthcare event we are organizing on Jan 30 in Brtislava to discuss advancements in oncology precision medicine and clinical data. Global leaders in the area of cancer treatment, bio-informatics and regulation will have the opportunity to share with you their latest insights and eBased on data from the World Health Organization, the situation with cancer mortality in Slovakia has improved significantly over the past years particularly in bronchus, lung and trachea cancers. In order to pursue further improvements in cancer mortality, it is of utmost importance to address the infrastructure issues by leveraging modern approaches in a variety of healthcare domains as well as by attracting clinical and preclinical research in precision medicine to Slovakia. Our company WHISE-Embleema is a key player in the area of personalized medicine driven digital healthcare and by studying Slovakia’s health profile we recognize its potential to attract significant interest in this domain.

Schedule of Events

  • 13:00 – Discussions

    Introduction from Prof.MUDr.Stanislav Špánik, CSc, State Secretary, Ministry of Health of the Slovak Republic: Priorities in public health and cancer in Slovakia

  • 13:30 – Discussions

    Pr. Alexander Eggermont, Chairman Cancer Core Europe: Immuno-oncology and precision medicine

  • 14:30 – Discussions

    Pr. Vahan Simonyan (WHISE Embleema): The importance of health data networks for advancing precision medicine

  • 15:00 – Discussions

    Dr. Frank Weichold (FDA): A regulator’s perspective on real-world data for precision medicineHave a cup of coffee to recharge for an exciting evening.

  • 15:30 PM- Discussions

    Robert Chu (WHISE Embleema): How to accelerate clinical research with patient-driven data ecosystems

  • 16:00 PM- Discussions

    Mr. Michal Pisoja, CEO AGEL: A health network’s perspective on the critical need for patient dataPr. Vahan Simonyan (WHISE Embleema): Precision medicine bio-informatics

  • 16:30 PM- Discussions

    Mr. Pierre Germain, former director of Gustave Roussy: Clinical data for cancer research

  • 17:00 PM- Closing Comments

    Robert Chu & Pr. Vahan Simonyan makes some closing comments to mark the end of the day’s discussions.

  • 17:00 PM – 19:00 PM Cocktails & Converstations

    Have a cocktail while you network with the speakers and other event attendees